Autoimmunity BioSolutions: $2 Million (Seed) Closed For Advancing Development Of ... - Pulse 2.0

Retrieved on: 2024-12-05 21:35:42

Tags for this article:

Click the tags to see associated articles and topics

Autoimmunity BioSolutions: $2 Million (Seed) Closed For Advancing Development Of ... - Pulse 2.0. View article details on hiswai:

Excerpt

ABS has developed monoclonal antibodies highly specific ... monoclonal antibodies specifically targeting sIL7R while sparing membrane-bound IL7R.

Article found on: pulse2.com